Porton Pharma Solutions

Porton Pharma Solutions, established in 2005, is a globally recognized pharmaceutical contract development and manufacturing organization (CDMO) operating within the Pharmaceuticals and Healthcare sectors. The company specializes in drug substance development and manufacturing, encompassing small molecules, biologics, and advanced therapy medicinal products. With a significant operational footprint, Porton Pharma Solutions manages over 20 sites and employs a workforce exceeding 4,300 professionals, providing comprehensive support from pre-clinical research through to commercial stages for a diverse client base of over 1,200 companies. The organization is actively expanding its research and development facilities to enhance its capabilities and enable earlier access to quality medicines for patients worldwide.

The company's extensive network and dedicated team are central to its service delivery. Porton Pharma Solutions is committed to upholding stringent global regulatory standards, including those set by the FDA and PMDA, ensuring the highest quality and compliance in all manufacturing processes. This dedication to excellence is supported by a substantial employee base, ranging from 5,000-10,000 employees, who contribute to the company's mission. Meet Porton Pharma Solutions's team to understand the expertise driving their operations and client success.

Porton Pharma Solutions's strategic focus on innovation and scalability positions it as a key partner in the pharmaceutical supply chain. The company's revenue stands at $100.0M, reflecting its substantial market presence and operational capacity. By continuously investing in advanced technologies and expanding its R&D capabilities, Porton Pharma Solutions aims to accelerate drug development timelines and facilitate the introduction of novel therapies. Their commitment extends to fostering strong client relationships builtView more...